During the forecast period, the growing demand for accurate and early diagnostic techniques, modernization and expansion of healthcare infrastructure, and considerable illness prevalence are projected to drive the ASEAN and North Asian Point of Care/Rapid Diagnostics market. However, a scarcity of trained healthcare providers and expensive out-of-pocket healthcare expenditures are limiting this market's growth.

Report (224 pages) The market for ASEAN and North Asian Point of Care/Rapid Diagnostics is predicted to increase at a CAGR of 13.0% from USD 2.0 billion in 2021 to USD 3.9 billion in 2026.

Request For Sample:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=219733165

The general healthcare environment in ASEAN and North Asian countries has improved due to rapid urbanisation and development. Furthermore, almost half of the population of Southeast Asia lives in cities. After the United States, the ASEAN area is anticipated to overtake the EU as the world's second-largest med-tech market, with most clients falling outside of the premium class. As more people are covered by universal insurance plans, favourable growth conditions will emerge. Furthermore, due to the increased demand for accurate and early diagnostic procedures, ASEAN and North Asian point of care diagnostics are being used.

Driver: Changing consumer preferences and increasing modernization of healthcare services are expected to boost the market for point-of-care diagnostics in target countries over the next decade.
The general healthcare environment in ASEAN and North Asian countries has improved due to rapid urbanisation and development. Furthermore, almost half of the population of Southeast Asia lives in cities. After the United States, the ASEAN area is anticipated to overtake the EU as the world's second-largest med-tech market, with most clients falling outside of the premium class. As more people are covered by universal insurance plans, favourable growth conditions will emerge. Furthermore, due to the increased demand for accurate and early diagnostic procedures, ASEAN and North Asian point of care diagnostics are being used.

Emerging markets have a lot of promise for growth.
For PoC diagnostic companies in the region, workflow automation and decentralisation of diagnostic services offer considerable revenue growth prospects over the next decade. Emerging health technology has focused attention on four areas that are driving decentralisation. Decentralized healthcare at home, Decentralized healthcare in clinics, Insurance companies and HMOs shifting their focus to digital solutions, and Major actors' responses to decentralisation are the four areas to watch. Automation systems were used by more over half of the labs in developed Asian countries, compared to only 28.7% in poor countries. When compared to smaller labs, large labs, defined as those processing over 1,000 samples per day, had a higher rate of adoption.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219733165

Key Players:

The major players in the ASEAN and North Asian Point of Care/Rapid Diagnostics market are Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Abbott Laboratories (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sysmex (Japan), Cardinal Health (US), Quidel (US), GE Healthcare (US) EKF Diagnostics (UK), bioMérieux SA (France), Accubiotech (China), PTS Diagnostics (US), Chembio Diagnostics (US) Trinity Biotech (Ireland), Johnson and Johnson(US), Sekisui Diagnostics (US), Nova Biomedical (US), Thermo Fisher Scientific (US), Ortho Clinical Diagnostics (US) and Bio-Techne (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


More Information:

https://www.prnewswire.com/news-releases/asean-and-north-asian-poin...